Abstract
β-secretase (BACE-1) plays a pivotal role in the β-Amyloid plaques formation, which is responsible for progressive cognitive and memory loss commonly found in Alzheimer disease patients. As a consequence, it has been considered as a good target for drug development efforts. Early work focused on the synthesis of peptidomimetics, but poor pharmacokinetics profile prevented advancing lead compounds to clinical trials. As an alternative, aminoimidazoles, aminohydantoins and aminopyridines derivatives that inhibit BACE-1 were designed. Herein we report statistically sound descriptor- based (r2 = 0.87, q2 = 0.85, 6 PCs) and fragment-based (r2 = 0.91, q2 = 0.84, 6 PCs) QSAR models, that show high predictive ability (r2 pred = 0.84, averaged r2 m=0.78) and underscore polar interactions that are important for BACE-1 inhibition.
Keywords: Alzheimer, β-Amyloid, Beta-secretase (BACE-1), 2D-QSAR, Hologram QSAR.
Medicinal Chemistry
Title:2D QSAR Studies on Series of Human Beta-secretase (BACE-1) Inhibitors
Volume: 10 Issue: 2
Author(s): Daniela Santos Cruz and Marcelo Santos Castilho
Affiliation:
Keywords: Alzheimer, β-Amyloid, Beta-secretase (BACE-1), 2D-QSAR, Hologram QSAR.
Abstract: β-secretase (BACE-1) plays a pivotal role in the β-Amyloid plaques formation, which is responsible for progressive cognitive and memory loss commonly found in Alzheimer disease patients. As a consequence, it has been considered as a good target for drug development efforts. Early work focused on the synthesis of peptidomimetics, but poor pharmacokinetics profile prevented advancing lead compounds to clinical trials. As an alternative, aminoimidazoles, aminohydantoins and aminopyridines derivatives that inhibit BACE-1 were designed. Herein we report statistically sound descriptor- based (r2 = 0.87, q2 = 0.85, 6 PCs) and fragment-based (r2 = 0.91, q2 = 0.84, 6 PCs) QSAR models, that show high predictive ability (r2 pred = 0.84, averaged r2 m=0.78) and underscore polar interactions that are important for BACE-1 inhibition.
Export Options
About this article
Cite this article as:
Cruz Santos Daniela and Castilho Santos Marcelo, 2D QSAR Studies on Series of Human Beta-secretase (BACE-1) Inhibitors, Medicinal Chemistry 2014; 10 (2) . https://dx.doi.org/10.2174/15734064113099990002
DOI https://dx.doi.org/10.2174/15734064113099990002 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Child and Adolescent Refugee Mental Health in Brazil: Literature Review and a Family Case Report
Adolescent Psychiatry Effects of Thiazolidinediones Beyond Glycaemic Control
Current Pharmaceutical Design May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?
Cardiovascular & Hematological Disorders-Drug Targets Gene-Activation Mechanisms in the Regression of Atherosclerosis, Elimination of Diabetes Type 2, and Prevention of Dementia
Current Molecular Medicine Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
Current Alzheimer Research Epigenetic Control of MicroRNA Expression and Aging
Current Genomics Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Recent Patents on CNS Drug Discovery (Discontinued) Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets Synaptic Elimination in Neurological Disorders
Current Neuropharmacology Repetitive Ritalin Treatment Modulates the Diurnal Activity Pattern of Young SD Male Rats
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Alzheimer Research Screening for Inhibitors of Microglia to Reduce Neuroinflammation
CNS & Neurological Disorders - Drug Targets Systems Biology Approaches to Pancreatic Cancer Detection, Prevention and Treatment
Current Pharmaceutical Design Micromorphology of the Yellow Cuticle in Social Wasps: The Presence of Rhabdomeric and Ciliary Peripheral Photoreceptors
Current Nanoscience Radiotracers in Oncology
Current Radiopharmaceuticals Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data
Current Drug Targets The Association between Migratory Factors and Emotional and Behavioural Symptoms in Very Recently Arrived Immigrant and Refugee Adolescents
Adolescent Psychiatry Sodium-Assisted Formation of Binding and Traverse Conformations of the Substrate in a Neurotransmitter Sodium Symporter Model
Current Drug Discovery Technologies COMMENTARY: Magnetic Resonance Techniques Applied to Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets